Cargando…
Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
SIMPLE SUMMARY: Anti-angiogenic therapies targeting the vascular endothelial growth factor (VEGF) signaling are established in the arsenal of cancer treatments. Despite the expectations, their benefits are temporary in cancer patients, partly due to the compensatory function of other angiogenic grow...
Autores principales: | Zahra, Fatema Tuz, Sajib, Md. Sanaullah, Mikelis, Constantinos M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003808/ https://www.ncbi.nlm.nih.gov/pubmed/33804681 http://dx.doi.org/10.3390/cancers13061422 |
Ejemplares similares
-
Expression of bFGF and VEGF in brain astrocytoma.
por: Shim, J. W., et al.
Publicado: (1996) -
The Quantitative Analysis of bFGF and VEGF by
ELISA in Human Meningiomas
por: Denizot, Yves, et al.
Publicado: (2006) -
VEGF and bFGF gene polymorphisms in Polish patients with B-CLL
por: Wróbel, Tomasz, et al.
Publicado: (2013) -
VEGF and bFGF Gene Polymorphisms in Patients with Non-Hodgkin's Lymphoma
por: Wróbel, Tomasz, et al.
Publicado: (2013) -
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
por: Markowska, Anna I., et al.
Publicado: (2010)